Cantourage Group SE Expands into Polish Medical Cannabis Market

Cantourage Group SE has entered the Polish medical cannabis market by exporting high-quality craft cannabis, partnering with Polish wholesaler PharmaVitae. This strategic move aligns with Cantourage's approach to capture underserved markets with substantial growth potential. Poland's medical cannabis market is anticipated to grow as regulatory frameworks evolve and public awareness increases. In 2023, the market had approximately 30,000 patients and a volume of 4.5 tons, expected to expand at a ~40% CAGR until 2028.

Sales from Poland are projected at €4-5 million for FY25, potentially exceeding €20 million annually in the next three to five years, making it a key market alongside Germany and the UK. Moreover, Cantourage aims for over 100% year-on-year sales growth to €49 million in FY24, with improved EBITDA margins. Political uncertainties in Germany present minimal threat to Cantourage's medical cannabis-focused business.